Can reactive donor screening results be presumed false positive following unstandardized testing procedures?

Autor:	Sepetiene, Ramune, Galli, Claudio, Bhatnagar, Sonu, Ali, Mohamed, Orjuela, Guillermo, Olson, Ellen, Robbins, Ninette, Kang, Jason
Předmět:	MEDICAL screening RAPID diagnostic tests CENTRIFUGATION AIDS serodiagnosis
Zdroj:	Vox Sanguinis; Sep2023, Vol. 118 Issue 9, p807-808, 2p
Abstrakt:	Combining these results with those of a rapid, qualitative HCV Ab assay and quantitative HCV cAg test, they report acute hepatitis C case positivity of 8.1%. In their original article recently published in I Vox Sanguinis i , Lucey et al. [[1]] presented an evaluation of signal-to-cut-off ratios (S/CO) of an approved antibodies against hepatitis C virus (anti-HCV) screening assay (Architect Anti-HCV antibody assay; Abbott GmbH, Germany), along with an alternative antibody test (Standard Q HCV Ab test; SD Biosensor, Korea) and an HCV core antigen (HCV cAg) test (Architect HCV Ag; Abbott GmbH, Germany) in order to propose a blood donor screening algorithm containing supplemental testing using screened reactive HCV samples ( I n i = 470). [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.